4//SEC Filing
Gingrich Jon S. 4
Accession 0001179110-17-015739
CIK 0000805928other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:53 PM ET
Size
8.2 KB
Accession
0001179110-17-015739
Insider Transaction Report
Form 4
AxoGen, Inc.AXGN
Gingrich Jon S.
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to purchase)
2017-12-18+32,600→ 32,600 totalExercise: $27.00Exp: 2027-12-18→ Common Stock (32,600 underlying) - Award
Restricted Stock Units
2017-12-18+5,500→ 5,500 total→ Common Stock (5,500 underlying)
Footnotes (3)
- [F1]All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock.
- [F3]All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
AxoGen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001711638
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 6:53 PM ET
- Size
- 8.2 KB